Search
Close this search box.

Head of Division

Professor Nombulelo Magula

Designation: Head of Division: Internal Medicine

Tel: 031 260 4505

Email: magulan@ukzn.ac.za

Campus: Nelson R Mandela School of Medicine

Research interests:

1. Strategies to end HIV as a public health threat
2. Intersection of Communicable and Non-Communicable Diseases, in particular, applying lessons learnt from the Covid-19 pandemic
3. Health Systems strengthening including strategies to open access to Specialist care at Community level
4. Implementation Science research

Professor Nombulelo Magula is the Head of Division of Internal Medicine and leader of the clinical team at Clairwood Hospital. Born and bred in KwaMashu, Durban, South Africa, she completed her BSc (Chemistry) at the University of Cape Town and Medicine at the Medical University of Southern Africa, followed by Specialist training in Internal Medicine at the University of KwaZulu-Natal. Prof Magula was subsequently awarded the Fogarty Fellowship to study MSc in Clinical research at the New England Medical Center and Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, USA. Her Masters Dissertation was titled “Adherence to HAART in the First Year of the Rollout Program at King Edward VIII Hospital, KwaZulu-Natal, South Africa”. On return to South Africa, she was awarded the Discovery Foundation Academic Fellowship and Medical Research Council of South Africa, Self-Initiated Research Grant and completed her PhD in Medicine at the University of KwaZulu-Natal with a thesis titled “Metabolic Complications of Antiretrovirals in a South African black population”.

She has a particular interest in the management of HIV disease and its intersection with non-communicable diseases. She serves as Key Opinion Leader for eThekwini Municipality for Fast-Track Cities for the International Association of Providers of AIDS Care (IAPAC) in collaboration with Joint United Nations Programme on HIV/AIDS (UNAIDS).

The emergence of the Covid-19 pandemic saw Prof Magula appointed as a member of the South African Ministerial Advisory Committee on Covid-19 guiding the country’s response to the Covid-19 pandemic. She was also appointed to serve on the Advisory Committee to the MEC for Health and Head of Health in KwaZulu-Natal, Chairperson for the Management of Covid-19 Team in KwaZulu-Natal. She served as Principal Investigator for the World Health Organization initiated international randomised trials of additional treatment for Covid-19 in hospitalised patients who are all receiving the local standard of care –Public health –SOLIDARITY TRIAL. She serves as co-Investigator and Principal Investigator in other local and international clinical trials and observational studies.

She serves on the National Institutes of Health’s National Heart, Lung and Blood Institute’s Data Safety and Monitoring Board. Prof Magula is a Commissioner for the IAPAC-Lancet HIV’s commission on the future of Urban HIV Responses. She Chairs the sub-Committee on Social Determinants of Health of the IAPAC-Lancet HIV Commission. She is the former President of the African Viral Care Society.

Prof Magula has previously served as a member of the UKZN Senate, Senate representative on Promotions Committees including the Senior Promotions Committee, Senate representative on the UKZN Council, and also on the Executive Committee of UKZN Council. She has served on Program and School review Committees at UKZN. She has also served as a member of Council for the College of Physicians of South Africa. Prof Magula represented South Africa as a member of the South African Delegation hosted by the US Government to the National Institutes of Health and the Centers for Disease Control, USA on the Global Health Security Agenda.

Prof Magula has a deep interest in issues that affect students. She is a member of the Founding Committee of the Tumelo Seliane Education Fund (TuSef). TuSef is an initiative of students and Alumni of the Nelson R Mandela School of Clinical Medicine, UKZN, in honour of the memory of one of the students, Tumelo Seliane, who left an indelible mark at the Medical School through his selfless service to his colleagues and the community. The goal is to raise a minimum of 1 million rand as an endowment fund and support students from the interest to maintain the endowment into perpetuity. More than R500 000 has been raised through the UKZN Foundation.

Her contribution in the resolution of the impasse during the 2016 #FeesMustFall Protests between UCT students and UCT Executive, as a member of the University of Cape Town Black Alumni Association (UCTABA), saw her being appointed as UCT Alumni Representative on the Institutional Reconciliation and Transformation Commission (IRTC) Steering Committee. The IRTC was formed as part of the agreement entered into, to end the 2016 protests. Prof Magula has also served on the UCT Alumni Advisory Board. She is passionate about youth empowerment and strives toward making the path smooth for the next generation and ensuring that they do not experience some of the difficulties she herself had to go through in her journey.

Prof Magula has oversight responsibility for Internal Medicine modules in the MBChB program (Integrated Approach to Illness/ Cardinal Symptoms of Disease CMED 3IC], Introductory Integrated Medicine [CMED4II], Integrated Medicine 1 [CMED4IM], Integrated Medicine 2 [CMED5IM2], Integrated Medicine 3 [CMED6IM], including the Nelson Mandela Fidel-Castro Collaboration Internal Medicine program until recently. In the time that she has served as the leader of Internal Medicine, the Division has graduated 82 Masters of Medicine, 21 Masters of Medical Sciences and 21 PhDs; translating into at least 82 Internal Medicine Specialists that have gone on to serve in the Private and Public Health Sectors of South Africa.

PUBLICATIONS

Journals 

  1. Riziki Ghislain, Manimani MSc; Muzumbukilwa, Willy Tambwe MSc; Magula, Nombulelo Risk factors for death in hospitalized COVID-19 patients in Africa: A systematic review and meta-analysis Medicine 102(35):p e34405, September 01, 2023. | DOI: 10.1097/MD.0000000000034405
  2. Nsika Sithole, Alison Castle, Siyabonga Nxumalo, Lusanda Mazibuko, Thabang Manyaapelo, Shafika Abrahams-Gessel, Siphephelo Dlamini, Dickman Gareta, Joanna Orne-Gliemann, Kathy Baisley, Max Bachmann, Nombulelo Magula, Thomas A. Gaziano, Mark J. Siedner, Protocol: Implementation evaluation of a combination intervention for sustainable blood pressure control in rural KwaZulu-Natal, South Africa (IMPACT BP): A three-arm, unblinded, parallel group individually randomized clinical trial, Contemporary Clinical Trials, Volume 131, 2023, 107258, ISSN 1551-7144, https://doi.org/10.1016/j.cct.2023.107258. (https://www.sciencedirect.com/science/article/pii/S1551714423001817)
  3. Wandile Sithole, Pillay, Somasundram, Mbanjwa Bavumile, Magula Nombulelo. A Convoluted Path to the Diagnosis of Hepatocellular Carcinoma in a resource Limited Setting. SAGE Open Medical Case Reports. 2023. Volume 11: 1–5
  4. Al-arbi KMS, Magula NP, Mody GM (2023) Tuberculosis remains a major burden in systemic lupus erythematosus patients in Durban, South Africa. Front Med. 10:1118390 doi: 10.3389/fmed.2023.1118390
  5. Karrim N, Byrne R, Magula N, Saman Y. Antihistamines for motion sickness (Review), Cochrane Database of Systematic Reviews 2022, Issue 10. Art. No.: CD012715
  6. Gumede N, Khan K, Lustig GJ, Archary D, Cele SV, Karim F, Magula NP, al. Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV). Clinical Infectious Diseases. 2022;75(1):e857–64
  7. Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, Cele S, Lustig G, Amoako D, Wolter N, Samsunder N, Sivro A, San JE, Giandhari J, Tegally H, Pillay S, Naidoo Y, Mazibuko M, Miya Y, Ngcobo N, Manickchund N, Magula N, Karim QA, von Gottberg A, Abdool Karim SS, Hanekom W, Gosnell BI; COMMIT-KZN Team; Lessells RJ, de Oliveira T, Moosa MS, Sigal A.Nat Commun. 2022 Oct 13;13(1):6057. doi: 10.1038/s41467-022-33371-0
  1. Khadija Khan, Farina Karim, Yashica Ganga, Mallory Bernstein, Zesuliwe Jule, Kajal Reedoy, Sandile Cele, Gila Lustig, Daniel Amoako, Nicole Wolter, Natasha Samsunder, Aida Sivro, James San, Jennifer Giandhari, Houriiyah Tegally, Sureshnee Pillay, Yeshnee NAidoo, Matilda Mazibuko, Yoliswa Miya, Nokuthula Ngcobo, Nithendra  Manickchund, Nombulelo Magula, Quarraisha Abdool Karim, Anne von Gottberg, Salim Abdool Karim, Willem Hanekom, Bernadett Gosnell, Richard Lessells, Tulio de Oliveira, Mahomed-Yunus Moosa, Alex Sigal. Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. Nat Commun 13, 4686 (2022). https://doi.org/10.1038/s41467-022-32396-9 10 August 2022
  2. Khadija Khan, Gila Lustig, Mallory Bernstein, Derseree Archary, Sandile Cele, Farina Karim, Munneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Yoliswa Miya, Ntombifuthi Mthabela, Nombulelo P. Magula, Richard Lessells, Tulio de Oliveira, Bernadett I. Gosnell, Salim Abdool Karim, Nigel Garrett, Willem Hanekom, Linda-Gail Bekker, Glenda Gray, Jonathan M. Blackburn, Mahomed-Yunus S. Moosa, and Alex Sigal for the COMMIT-KZN Team. Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living with Human Immunodeficiency Virus (HIV). Clinical Infectious Diseases, Ad26.CoV2.S Vaccination in PLWH. CID 2022;XX (XX): 1 – 8
  3. Khadija Khan, Farina KarimSandile CeleKajal ReedoyJames Emmanuel SanGila LustigHouriiyah TegallyYuval RosenbergMallory Bernstein, Zesuliwe JuleYashica GangaNokuthula NgcoboMatilda MazibukoNtombifuthi MthabelaZoey MhlaneNikiwe MbathaYoliswa MiyaJennifer Giandhari, Yajna RamphalTaryn NaidooAida SivroNatasha SamsunderAyesha B. M. KharsanyDaniel AmoakoJinal N. BhimanNithendra ManickchundQuarraisha Abdool KarimNombulelo MagulaSalim S. Abdool KarimGlenda GrayWillem HanekomAnne von GottbergCOMMIT-KZN TeamRon MiloBernadett I. GosnellRichard J. LessellsPenny L. MooreTulio de OliveiraMahomed-Yunus S. Moosa& Alex Sigal. Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature (2022). https://doi.org/10.1038/s41586-022-04830-x   Nature Vol 607 July 2022
  1. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses WHO Solidarity Trial Consortium. Lancet 2022; 399: 1941–53 Published Online May 2, 2022 https://doi.org/10.1016/ S0140-6736(22)00519-0. Author list, page 14: Microsoft Word – Solidarity Annex Part1_MPP_17-Jan-2022.docx (els-cdn.com)
  2. Manimani Riziki Ghislain, Gloire – Aimé Mushebenge,  Nombulelo Magula. Morbidity and mortality in the antiretroviral era in Sub-Saharan Africa : A systematic review. MEDICINE. October 29, 2021 – Volume 100 – Issue 43 – p e27342 doi: 10.1097/MD.0000000000027342
  3. Waasila Jassat, Cheryl Cohen, Stefano Tempia, …, Nombulelo Magula, DATCOV author group, Lucille Blumberg1 COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence setting. Lancet HIV www.thelancet.com/hiv Vol 8 September 2021. https://doi.org/10.1016/ S2352-3018(21)00151-X
  4. Manimani Riziki Ghislain, Lungile Puritty Gumede, Nombulelo Magula et al. Morbidity and mortality in the modern antiretroviral treatment era in a tertiary teaching hospital in Durban, South Africa., 08 March 2022, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-1426462/v1]
  5. Ghislain MR, Mushebenge GA, Magula N. Cause of hospitalization and death in the antiretroviral era in Sub-Saharan Africa published 2008-2018: A systematic review. Medicine (Baltimore). 2021 Oct 29;100(43):e27342. doi: 10.1097/MD.0000000000027342. PMID: 34713822; PMCID: PMC8556022.
  6. Pillay S, Magula N , A trio of infectious diseases and pulmonary embolism:A developing worlds reality . SAfrJHIV Med .2021;22(1) a1192htt//doi.org10.4102/sajhivmed,v22;1.1192 https//://doi.rg/10.42102/sajhivmed.v22i1.1192 
  7. Pillay S, Magula N.P Treatment outcomes of Gene Xpert positive Tuberculosis patients in Kwa Mashu Community Health Centre , KwaZulu –Natal, South Africa-A retrospective review .South Afr J Inf Diseases https://doi.org/10.4102/sajid.v36i1.217.
  8. Olamide O Todowede, Benn Sartorius, Nombulelo Magula, Aletta E. Schutte. Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected in Durban, South Africa Diabetology & Metabolic Syndrome (2019) 11:105
  9. T Sookan, MJ Ormsbee, J Antonio, NP Magula, AA Motala, UG Lalloo, AJ McKune. Improvement in muscular strength in HIV-infected individuals receiving ART. J. Funct. Morphol. Kinesiol. 2019, 4, 66; doi:10.3390/jfmk4030066
  10. Takshita Sookan, Jose Antonio, Michael J Ormsbee, Nombulelo P Magula, Ayesha A Motala, Umesh G Lalloo, Andrew J McKune. Resistance training reduces T helper cytokine levels but not cardiometabolic risk factors in HIV-infected individuals receiving art (2018). Imprensa da Universidade de Coimbra
  11. Assaram S, MashambaThompson TP, Magula NP. Risk factors and comorbidities associated with changes in renal function among antiretroviral treatment-naïve adults in South Africa: A chart review. S Afr J HIV Med. 2018;19(1), a770. https://doi.org/ 10.4102/sajhivmed.v19i1.770
  12. Jeeha Rajeev, David Lee Skinner, Kim de Vasconcellos, Magula Nombulelo Princess,et. al. Serum procalcitonin levels predict acute kidney injury in critically ill patients; Nephrology NEP-2017-0492.R1
  13. Naidoo, Larisha & Magula, N.P. & Moodley, Yoshan. (2017). Audit of Medical Admissions at a Rural South African Primary Care Hospital Between 2012 and 2016. Online Journal of Health and Allied Sciences. 16.
  14. Janani Naicker, VG Naidoo, KA Newton, N Magula, Severe iron deficiency anaemia caused by hookworm infestation – A Case Report. South African Gastroenterology 2017;Issue 3 Vol 15:11-13.
  15. S Gounden, R Perumal & NP Magula, Extrapulmonary tuberculosis in the setting of HIV hyperendemicity at a tertiary hospital in Durban, South Africa. Southern African Journal of Infectious Diseases 2017;1(1):1-8
  16. Shirelle Assaram, Nombulelo P Magula, Suman MewaM Kinoo and Tibani P Mashamba-Thompson Systematic Reviews (2017) 6:200
  17. Karrim N, Magula N, Saman Y. Antihistamines for motion sickness (Protocol), Cochrane Database of Systematic Reviews 2017, Issue 7. Art. No.: CD012715.
  18. Sithembile Ngidi, Nombulelo Magula, Ben Sartorius, Poovan Govender, Thandinkosi E Madiba. Incidence of Chemotherapy-induced neutropaenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy. South African Medical Journal 2017;107(7):595-601
  19. Singh M, Magula NP, Haripersadh S, Assounga A. A comparison of urban and rural patients with chronic kidney disease referred to Inkosi Albert Luthuli Hospital in Durban, South Africa Accepted: African Journal of Nephrology 2017; Volume 20, No 1, 2017, 34-38
  20. Assaram S, Magula NP, Mewa Kinoo S, Mashamba-Thompson TP. Renal manifestations of HIV during the antiretroviral era in South Africa: a systematic scoping review. Syst Rev. 2017 Oct 13;6(1):200. doi: 10.1186/s13643-017-0605-5. PMID: 29029647; PMCID: PMC5640942.
  21. Yusuf Moolla, Zaheer Moolla, Tarylee Reddy, Nombulelo Magula. The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals, South African Family Practice 2015, DOI: 10.1080/20786190.2015.1073895
  22. Magula N, Dedicoat M. Low dose versus high dose stavudine for treating people with HIV infection (REVIEW). Cochrane Database Syst Rev. 2015 Jan 28;1:CD007497. doi: 10.1002/14651858.CD007497.pub2.
  23. N Magula, AA Motala, UG Lalloo. The prevalence and incidence of diabetes mellitus and other disorders of glycaemia in South African black patients of antiretroviral therapy. JEMDSA 2014; 19: 16
  24. NP Magula, ND Madala, Y Kriel, V Bayi, NP Duze, TC Manzini, R Matshela, DP Naidoo, BM Mayosi. Prevalence of drug resistant tuberculosis in patients presenting with a large pericardial effusion at King Edward VIII Hospital. International Journal of Infectious Diseases 2014. Vol 21, SUPPL 1. Abstract 40.021
  25. Takshita Sookan, Andrew McKune, Michael Ormsbee, Jose Antonio, Nombulelo Magula, Umesh Lalloo,  Ayesha Motala. Effect of a progressive resistance training program and whey protein intake on quality of life in human immunodeficiency virus infected individual receiving antiretroviral therapy. South African Journal of   Sports Medicine(2015) , Vol 27
  26. N Magula, AA Motala, UG Lalloo. The prevalence and incidence of diabetes mellitus and other disorders of glycaemia in South African black patients of antiretroviral therapy. International Journal of Infectious Diseases 2014. Vol 21, SUPPL 1. Abstract Pre. 018
  27. M. Mayosi, M. Ntsekhe, J Bosch, S Pandie, H Jung, F Gumedze, J Pogue, L Thabane, M. Smieja, V. Francis, L. Joldersma, KM Thomas, B Thomas, A.A. Awotedu, N.P. Magula, D.P. Naidoo, A Damasceno, A.C. Banda, B. Brown, P. Manga, B. Kirenga, et.al. for the IMPI Investigators. Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis. N Engl J Med 2014; 371: 1121-1130. DOI 10.1056/NEJMoa 1407321
  28. Madiba TE, Magula NP. Exposure to Human Immunodeficiency Disease. What Precautions for the Healthcare Professional? East & Centr Afr J Surg.March/April 2010; 15(1). 9-15
  29. Bongani M. Mayosi, Mpiko Ntsekhe, Jackie Bosch, Janice Pogue, Freedom Gumedze, Motasim Badri, Hyejun  Jung, Shaheen Pandie, Marek Smieja, Lehana Thabane, Veronica Francis, Kandithal M. Thomas, Baby Thomas, Abolade A. Awotedu, Nombulelo P. Magula, Datshana P. Naidoo, Albertino Damasceno, et. al. Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial:  A 2 × 2  factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditisAm Heart J.Feb;165(2):109-115.e3. doi: 10.1016/j.ahj.2012.08.006. Epub 2012 Dec13
  30. Magula N, Dedicoat M. Low dose versus high dose stavudine for treating people with HIV infection (PROTOCOL). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD007497. DOI: 10.1002/14651858.CD007497
  31. Bongani M Mayosi, Charles Shey Wiysonge, Mpiko Ntsekhe, Freedom Gumedze, Jimmy A Volmink, Gary Maartens, Akinyemi Aje, Baby M Thomas, Kandathil M Thomas, Abolade A Awotedu, Bongani Thembela, Phindile Mntla, Frans Maritz, Kathleen Ngu Blackett, Duquesne C Nkouonlack, Vanessa C Burch, Kevin Rebe, Andy Parrish, Karen Sliwa, Brian Z Vezi, Nowshad Alam, Basil G Brown, Trevor Gould, Tim Visser, Nombulelo P Magula, Patrick J Commerford. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J. 2008 Jan;98(1):36-40.
  32. Douglas P. Olson,* Cheryl L. Day, Nombulelo P Magula, Faieza Sahid, and M. Yunus Moosa. Case Report: Cutaneous Extensively Drug-Resistant Tuberculosis J. Trop. Med. Hyg., 77(3), 2007, 551-554
  33. Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, Trikalinos T, Lau J. Breastfeeding and Maternal and Infant Health Outcomes in Developed Countries. Evid Rep Technol Assess. 2007 April; (153): 1-186. Review
  34. Magula NP, Samuel EY, Hlela C, Schmid C, Moosa MYS, Wilson IB. Experiences of the first 100 patients in a highly active antiretroviral treatment (HAART)Conference. Toronto, Abstract: CDB0630, August 13-18,2006
  35. Mayosi BM, Wiysonge CS, Ntsekhe M,Volmink JA, Gumedze F,Maartens G, Aje A,Thomas BM, Thomas KM, Awotedu AA,Thembela B,Mntla P,Maritz F, Blackett KN,Nkouonlack DC,Burch VC,Rebe K,Parish A,Sliwa K, Vezi BZ, Alam N,Brown,G,Gould T,Visser T,Shey MS,Magula NP,Commerford PJ. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infectious disease 2006; 6:2
  36. Ferris DC, Dawood H, Magula N, Lalloo UG. Application of an algorithm to predict CD4 lymphocyte count below 200 cells/mm3 in HIV-infected patients in South Africa, AIDS 2004 July 2; 18(10): 1481-2
  37. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovascular Journal of South Africa 5 Sept/Oct 2003, Vol. 14, No.5: 231-237
  38. Shava J, Kawesa P, Magula N, Theron E. Unusual presentation of abdominal pregnancy. Cent Afr J Med. 1995 Sep;41(9):293
  39.  

PUBLICATIONS 

BOOKS /CHAPTERS IN BOOKS/MEDICAL NEWSLETTERS 

  1. Critical care Focus Volume 2, Nombulelo P Magula. com.
  2. Sandhya Singh, Nombulelo Magula, Pamela Naidoo, Kwanele Asante, Yogan Pillay. The South African Health Reforms 2015 -2020: The Road Ahead. Chapter 9 Non–communicable Diseases. Published  Nov 3, 2022; 158-177. ISBN 978-0-6397-2368-6
  3. Magula N, Singh A. Human Immunodeficiency Virus, Myocardium, Pericadium, Vascular, Antiretroviral treatment, Atherosclerosis ESC Textbook of Cardiovascular Medicine 3rd edition, Oxford University Press, year, Section 028:  HIV
  1. Magula N, Perumal R, Apalata T. Antiretrovial treatment, Cardiovascular disease, Atherosclerosis, Human Immunodefeciency Virus, Inflammation, ESC Textbook of Cardiovascular Medicine 3rd edition, Oxford University Press, year, Section 028:  HIV
  1. Perumal R, Magula N. Pericarditis, Myocarditis, Myopericarditis, Tuberculosis, HIV, ESC Textbook of Cardiovascular Medicine 3rd edition, publisher, year, Section 028:  HIV
  1. Madiba TE, S Thomson, P Magula. Surgical aspects of HIV infection. In Adeloye A, Adekunle OO, Awojobi OA (Eds). Davey’s Companion to Surgery in Africa. 3rd ed. Acecool Medical Publishers, Eruwa, Nigeria, 2009; 160-167

 

MEDIA AND COMMUNITY EDUCATION

  1. Multiple media platforms providing education on Covid-19: newspapers (regional and national, English and isiZulu), radio (English, isiZulu, isiXhosa and seSotho), National Television channels
  2. Presented clinical referral pathway throughout the KZN health districts: “COVID-19 Clinical Pathway and Referral Protocol and Clinical Management” as part of Covid-19 response.
  3. Long Covid-19 and Determinants of Clinical Outcomes https://www.youtube.com/watch?v=pWCUAHxXvZk
  1. Living life Amidst the Covid-19 Pandemic. This Opinion-Editorial was originally published in The Starand Daily News on 30 September 2020 https://chs.ukzn.ac.za/news/living-life-amidst-the-covid-19-pandemic/
  1. COVID-19 Pandemic | Pros and cons of the move to lockdown alert level 1: Prof Nombulelo Magula https://www.youtube.com/watch?v=gpBj0Bwd-Q4
  1. Professor Bulie Magula on SA’s latest Covid-19 related deaths …https://www.youtube.com/watch?v=ugx5kZuP_i0
  1. Professor Nombulelo Magula is Head of UKZN’s Department of Internal medicine and serves on the COVID-19 Ministerial Advisory Committee for the National Minister of Health in South Africa. https://ukzn.ac.za/news/professor-nombulelo-magula/
  1. Helping us prepare for the 3rd wave is UKZN’s @ BulieMagula. 03 Mar 2021 https://twitter.com/UKZNCHS/status/1366665274053824512
  1. The Doctor Confronting COVID-19 After Decades of Fighting HIV. December 14, 2020. https://www.vice.com/en/article/4ada8j/the-doctor-confronting-covid-19-after-decades-of-fighting-hiv Changes to South Africa’s coronavirus advisors. 29 September 2020 https://businesstech.co.za/news/government/436525/changes-to-south-africas-coronavirus-advisors/
  1. KZN contingent on Mkhize’s Advisory Committee on COVID-19. 24 June 2020 https://www.medicalbrief.co.za/archives/kzn-contingent-on-mkhizes-advisory-committee-on-covid-19/
  1. UKZN academics serve on COVID-19 Ministerial Advisory Committee Issued by University of KwaZulu-Natal, 23 Jun 2020
  2. Head of Medicine at the University of KwaZulu-Natal, Professor Nombulelo Magula explains a few facts on COVID-19 and its dangers. 4 April https://sacoronavirus.co.za/2020/04/04/facts-on-covid-19-from-prof-nombelelo-magula/ https://pressoffice.mg.co.za/content/4r1ly7Rbr1r7pmda
  1. South Africa Delegation Meeting. October 6, 2016 https://www.centerforhealthsecurity.org/our-work/events/2016-South-Africa-Delegation-Meeting/
  1. HIV Heart and Mind http://drill.org.za/hiv-heart-and-mind/
  1. Professor Bulie Magula, Class of ’85 https://inanda.org/alumnae/alumnae-profiles/42-alumnae/206-bulie-magula.html

Share This Page